PubRank

Ed Wilkins

Author PubWeight™ 23.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010 9.61
2 British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008 3.67
3 British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med 2011 1.17
4 The cost-effectiveness of early access to HIV services and starting cART in the UK 1996-2008. PLoS One 2011 1.09
5 British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med 2014 1.01
6 Nevirapine use in HIV-1-infected children. AIDS 2003 0.99
7 British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Med 2013 0.98
8 Tumefactive demyelination-an unusual neurological presentation of HIV. Clin Infect Dis 2010 0.88
9 Diagnostic accuracy of the Recognition of Stroke in the Emergency Room (ROSIER) score and CT brain in an HIV population. J Infect 2013 0.83
10 Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies. J Antimicrob Chemother 2011 0.81
11 Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008. PLoS One 2012 0.79
12 Pseudohepatic tumour associated with secondary syphilis in an HIV-positive male. Int J STD AIDS 2006 0.79
13 Neurological complications in HIV. Clin Med 2011 0.79
14 UK national audit of sexual health care for people with HIV infection: case-notes audit. Int J STD AIDS 2007 0.79
15 Opportunistic infections in HIV disease. Br J Nurs 2010 0.75
16 Severe acute respiratory syndrome (SARS): a review. Clin Med 2004 0.75
17 UK national audit of sexual health care for people with HIV infection: clinic policies. Int J STD AIDS 2007 0.75
18 Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients. Antivir Ther 2003 0.75